UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Journal of hematology and oncology, 2018-12, Vol.11 (1), p.141-141, Article 141

2018

Volltextzugriff (PDF)

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Journal of hematology and oncology, 2022-07, Vol.15 (1), p.1-86, Article 86

2022

Volltextzugriff (PDF)

Neuronal Nitric Oxide Synthase Regulates Depression-like Behaviors in Shortening-Induced Obese Mice

Nutrients, 2022-10, Vol.14 (20), p.4302

2022

Volltextzugriff (PDF)

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Journal of hematology and oncology, 2024-04, Vol.17 (1), p.23-13, Article 23

2024

Volltextzugriff (PDF)

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Journal of medical case reports, 2022-12, Vol.16 (1), p.459-459, Article 459

2022

Volltextzugriff (PDF)

Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1

Acta pharmacologica Sinica, 2011-02, Vol.32 (2), p.182-187

2011

Volltextzugriff (PDF)

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

American journal of hematology, 2008-03, Vol.83 (3), p.185-188

2008

Volltextzugriff (PDF)

P874: LONG‐TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR‐B38M CAR‐T – AT LEAST 5‐YEAR FOLLOW‐UP IN LEGEND‐2

HemaSphere, 2023-08, Vol.7 (S3), p.e9841889-n/a

2023

Volltextzugriff (PDF)

Effect of granulocyte colony-stimulating factor Priming Combined with Low-dose cytarabine and homoharringtonine in Higher Risk myelodysplastic syndrome Patients

Leukemia research, 2016-09, Vol.48, p.57-61

2016

Volltextzugriff (PDF)

Cloning of New Antigen Gene MLAA-34 Promoter and Identification of Core Region in Acute Monocytic Leukemia

Zhongguo shi yan xue ye xue za zhi, 2019-06, Vol.27 (3), p.641

2019

Volltextzugriff (PDF)

Effect of G-CSF on induction of ENA-78 and IL-8 in the patients with malignant lymphoma

Zhongguo shi yan xue ye xue za zhi, 2014-04, Vol.22 (2), p.344

2014

Volltextzugriff (PDF)

Effects of Thalidomide on Peripheral Blood Th17 Cells of Patients with Multiple Myeloma

Zhongguo shi yan xue ye xue za zhi, 2015-10, Vol.23 (5), p.1341

2015

Volltextzugriff (PDF)

Therapeutic effects of porcine versus rabbit antithymocyte globulins for treatment of severe aplastic anemia

Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2016-03, Vol.36 (3), p.303

2016

Volltextzugriff (PDF)

Clinical Characteristics,Treatment Strategies and Prognostic Factors of 254 Cases of Non Hodgkin's Lymphoma

Zhongguo shi yan xue ye xue za zhi, 2016-08, Vol.24 (4), p.1044

2016

Volltextzugriff (PDF)

Intracortical microstimulation parameters modulate flight behavior in pigeon

Journal of integrative neuroscience, 2019-03, Vol.18 (1), p.23-32

2019

Volltextzugriff (PDF)

Clinical Study of Non Hodgkin's Lymphoma Treated with Enhanced Chemotherapy Regimen and Increased Treatment Courses

Zhongguo shi yan xue ye xue za zhi, 2015-12, Vol.23 (6), p.1612

2015

Volltextzugriff (PDF)

Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Zhongguo shi yan xue ye xue za zhi, 2015-04, Vol.23 (2), p.369

2015

Volltextzugriff (PDF)

Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

Acta pharmacologica Sinica, 2005-05, Vol.26 (5), p.598-602

2005

Volltextzugriff (PDF)

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T: At least 5-year follow-up in LEGEND-2

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.8010-8010

2023

Volltextzugriff (PDF)

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan

Zhongguo shi yan xue ye xue za zhi, 2007-06, Vol.15 (3), p.478

2007

Volltextzugriff (PDF)

Anti-tumor effect of two adjuvants of CpG ODN on leukemic tumor in mouse models

Zhongguo shi yan xue ye xue za zhi, 2007-10, Vol.15 (5), p.1042

2007

Volltextzugriff (PDF)

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease–a Single Institution Observation in China

Blood, 2020-11, Vol.136 (Supplement 1), p.6-6

2020

Volltextzugriff (PDF)

Computational Model for Electrical Resistivity of Soil–Rock Mixtures

Journal of materials in civil engineering, 2016-08, Vol.28 (8)

2016

Volltextzugriff (PDF)

Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma

Blood, 2018-11, Vol.132 (Supplement 1), p.5393-5393

2018

Volltextzugriff (PDF)

1 – 25 von 255

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(188)
Mit Volltextzugriff
(209)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(204)
Chinesisch
(52)

Erscheinungsjahr

n.n

Thema

Science & Technology
(142)
Life Sciences & Biomedicine
(89)
Humans
(59)
Male
(40)
Technology
(38)
Female
(31)
Physical Sciences
(30)
Adult
(27)
Animals
(27)
Engineering
(26)
Middle Aged
(26)
Aged
(19)
Chemistry
(17)
Neurosciences
(12)
Adolescent
(11)
Materials Science
(11)
Mice
(11)
Chemistry, Multidisciplinary
(10)
Materials Science, Multidisciplinary
(10)
Neurosciences & Neurology
(10)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A phase 1, open-label study of LCAR-B38M, a chimeric antigen receptor T cell therapy directed against B cell maturation antigen, in patients with relapsed or refractory multiple myeloma

Four-year follow-up of LCAR-B38M in relapsed or refractory multiple myeloma: a phase 1, single-arm, open-label, multicenter study in China (LEGEND-2)

Neuronal Nitric Oxide Synthase Regulates Depression-like Behaviors in Shortening-Induced Obese Mice

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment with LCAR-B38M CAR T cells: 5-year follow-up of the LEGEND-2 trial

Five-year remission without disease progression in a patient with relapsed/refractory multiple myeloma with extramedullary disease treated with LCAR-B38M chimeric antigen receptor T cells in the LEGEND-2 study: a case report

Novel neuroprotectant chiral 3-n-butylphthalide inhibits tandem-pore-domain potassium channel TREK-1

Combination chemotherapy with low‐dose cytarabine, homoharringtonine, and granulocyte colony‐stimulating factor priming in patients with relapsed or refractory acute myeloid leukemia

P874: LONG‐TERM REMISSION AND SURVIVAL IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AFTER TREATMENT OF LCAR‐B38M CAR‐T – AT LEAST 5‐YEAR FOLLOW‐UP IN LEGEND‐2

Effect of granulocyte colony-stimulating factor Priming Combined with Low-dose cytarabine and homoharringtonine in Higher Risk myelodysplastic syndrome Patients

Cloning of New Antigen Gene MLAA-34 Promoter and Identification of Core Region in Acute Monocytic Leukemia

Effect of G-CSF on induction of ENA-78 and IL-8 in the patients with malignant lymphoma

Effects of Thalidomide on Peripheral Blood Th17 Cells of Patients with Multiple Myeloma

Therapeutic effects of porcine versus rabbit antithymocyte globulins for treatment of severe aplastic anemia

Clinical Characteristics,Treatment Strategies and Prognostic Factors of 254 Cases of Non Hodgkin's Lymphoma

Intracortical microstimulation parameters modulate flight behavior in pigeon

Clinical Study of Non Hodgkin's Lymphoma Treated with Enhanced Chemotherapy Regimen and Increased Treatment Courses

Cohort Study on GHA and New Combined Priming Chemotherapeutic Regimens in Treatment of Refractory Acute Myeloid Leukemia and Myelodysplastic Syndrome

Mycophenolate mofetil as a treatment for refractory idiopathic thrombocytopenic purpura

Long-term remission and survival in patients with relapsed or refractory multiple myeloma after treatment of LCAR-B38M CAR-T: At least 5-year follow-up in LEGEND-2

Indoleamine 2, 3-dioxygenase expression in cells of human acute monocyte leukemia (M(5)) and acute lymphocyte leukemia and therapeutic effect of its inhibitor 1-methyl tryptophan

Anti-tumor effect of two adjuvants of CpG ODN on leukemic tumor in mouse models

Chimeric Antigen Receptor T Cell Therapy in the Relapsed or Refractory Multiple Myeloma with Extramedullary Disease–a Single Institution Observation in China

Computational Model for Electrical Resistivity of Soil–Rock Mixtures

Long-Term Follow-up of a Phase 1, First-in-Human Open-Label Study of LCAR-B38M, a Structurally Differentiated Chimeric Antigen Receptor T (CAR-T) Cell Therapy Targeting B-Cell Maturation Antigen (BCMA), in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Efficacy and Adverse Reactions of Gemcitabine Combined with Cyclophosphamide, Vinblastine and Prednisone Hydrogenation Regiments in Relapse and/or Refractory Non-Hodgkin's Lymphoma

Suchergebnisse filtern